Sign up for email alerts to receive notifications of new articles published in Ophthalmology and Eye Diseases
Elevated IOP in clinical practice is usually seen in glaucoma or ocular hypertension. Glaucoma affects 60 million people worldwide and 8.4 million are bilaterally blind from this chronic disease.1 Options for reducing IOP rely on pharmacological agents, laser treatments and surgery which may be penetrating or non-penetrating. The last twenty years has seen significant changes in all of these strategies. This review aims to cover these clinical options and introduce some of the new technologies currently in development for the clinical lowering of IOP.
PDF (1004.00 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
PMC HTML
The publishing process was fast and convenient. The journal staff were extremely helpful and prompt in responding to questions and issues related to the submission. The online submission and revision process was easy and staff were readily available to answer any questions. The reviewers' comments were insightful, very constructive and extremely helpful. The author interface is user-friendly. The publishing process is fast and convenient. I highly recommend others practitioners and researchers to consider Libertas Academica ...
Facebook Google+ Twitter
Pinterest Tumblr YouTube